Drawing for NUNTIUS

USPTO serial 99469765

NUNTIUS

Status 688Notice of Allowance
Filing date
Oct 29, 2025
Status date
May 26, 2026
Registration date
Examiner
EVANKO, PATRICIA MALESARDI

Need help with NUNTIUS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Deadline: November 26th, 2026

Owner

  • Thomas Rhee

    Tampa, FL, US

  • Thomas Rhee

    Tampa, FL, US

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic products taken orally, namely, pills that induce bronzing of the skin; Nasal cleaning preparations for personal sanitary purposes; Topical skin sprays for cosmetic purposes; Wrinkle-minimizing cosmetic preparations for topical facial use; Topical herbal cream for firming and enhancing breasts; Skin and body topical lotions, creams and oils for cosmetic useACTIVE
005Oral analgesics; Medicated oral care gels; Medicated brush-on oral care gels; Oral spray for the cessation of smoking; Ibuprofen for use as an oral analgesic; Nasal and oral spray preparations for use as central nervous system stimulants; Materials for crowns and bridges for dental use and for oral prophylaxis; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Nasal rinse; Nasal spray preparations; Nasal sprays for medical purposes; Nasal cleaning preparations for medical purposes; Nasal drops for the treatment of allergies; Saline solution for sinus and nasal irrigation; Concentrated saline capsules for sinus and nasal irrigation; Dry ingredients for making a saline solution for sinus and nasal irrigation; Pharmaceutical preparations, namely, dantrolene sodium for injection; Topical anesthetics; Topical analgesics; Topical analgesic creams; Alcohol for topical use; Topical first aid gel; Topical dermatological preparations that treat insect bites and stings; Topical gel for medical and therapeutic use, namely, ultrasound gel; Non-medicated topical gel for the prevention and treatment of allergies; Fluid for the topical fluoridation of tooth enamel and decay prevention; Non-medicated topical gel for the prevention and treatment of cold and flu; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Topical gel for medical and therapeutic treatment of sprains, strains, fracture, osteoarthritis, osteoporosis, decay, PAD, neuropathy.; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Intravenous bags sold filled with botanical compoundsACTIVE

Prosecution history

DateCodeEvent
Jul 24, 2026EISUTEAS STATEMENT OF USE RECEIVED
May 26, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 31, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2026PUBOPUBLISHED FOR OPPOSITION
Mar 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2026DOCKASSIGNED TO EXAMINER
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Oct 29, 2025NWAPNEW APPLICATION ENTERED

Related guidance